Glass House Brands (GLAS) Other Operating Expenses (2020 - 2026)
Glass House Brands' (GLAS) quarterly Other Operating Expenses came in at -$1.3 million in Q1 2026, down 1500.0% year-on-year from $92000.0 in Q1 2025, and down 118.56% on a QoQ basis from $6.9 million in Q4 2025.
Glass House Brands (GLAS) Other Operating Expenses (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Other Operating Expenses data on file, last reported at -$1.3 million in Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 1500.0% year-over-year to -$1.3 million in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 978.47% decrease from a year earlier, with the FY2025 full-year figure at $26.7 million, down 8.2% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$1.3 million, down from $6.9 million in the prior quarter.
- Over the last five years, Other Operating Expenses for GLAS reached as high as $7.1 million in Q2 2023 and fell as low as -$633.8 billion in Q3 2022.
- Historically, Other Operating Expenses has averaged -$52.8 billion across 5 years, with a median of $58500.0 in 2024.
- Across the five-year window, Other Operating Expenses soared 101.15% in 2022 and tumbled 9691.07% in 2025, its largest moves.
- Year by year, Other Operating Expenses stood at -$5.5 million in 2022, then surged by 228.54% to $7.1 million in 2023, then sank by 99.14% to $61000.0 in 2024, then surged by 11277.05% to $6.9 million in 2025, then tumbled by 118.56% to -$1.3 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$1.3 million in Q1 2026, $6.9 million in Q4 2025, and -$2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | 6.94 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Jun 30, 2025 | -5.37 Mn |
| Mar 31, 2025 | 92,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Jun 30, 2023 | 7.10 Mn |
| Dec 31, 2022 | -5.52 Mn |
| Sep 30, 2022 | -633.78 Bn |
| Jun 30, 2022 | 5.41 Mn |
| Mar 31, 2022 | 4.64 Mn |
| Dec 31, 2021 | -6.15 Mn |
| Sep 30, 2021 | 97.86 Bn |
| Jun 30, 2021 | 2.69 Mn |
| Mar 31, 2021 | 4.08 Mn |
| Dec 31, 2020 | 1,268.65 Bn |
| Sep 30, 2020 | 1.05 Mn |
| Mar 31, 2020 | 1.18 Mn |